4.1 Review

Pathophysiology, classification, and MRI parallels in microvascular disease of the heart and brain

Journal

MICROCIRCULATION
Volume 27, Issue 8, Pages -

Publisher

WILEY
DOI: 10.1111/micc.12648

Keywords

ferumoxytol; ischemia; magnetic resonance imaging (MRI); microvascular disease; stroke

Funding

  1. American Heart Association [18TPA34170049]
  2. National Institutes of Health [R01NS078494, R21CA223757, P50CA211015, R01HL127153, R01HL137562]
  3. Veterans Health Administration [I01-CX001901]

Ask authors/readers for more resources

Diagnostic imaging technology in vascular disease has long focused on large vessels and the pathologic processes that impact them. With improved diagnostic techniques, investigators are now able to uncover many underlying mechanisms and prognostic factors for microvascular disease. In the heart and brain, these pathologic entities include coronary microvascular disease and cerebral small vessel disease, both of which have significant impact on patients, causing angina, myocardial infarction, heart failure, stroke, and dementia. In the current paper, we will discuss parallels in pathophysiology, classification, and diagnostic modalities, with a focus on the role of magnetic resonance imaging in microvascular disease of the heart and brain. Novel approaches for streamlined imaging of the cardiac and central nervous systems including the use of intravascular contrast agents such as ferumoxytol are presented, and unmet research gaps in diagnostics are summarized.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available